Heroin Rehab

Heroin rehab works best when medication leads the way — and with today's supply laced with fentanyl, getting into treatment has never mattered more. Here's what real recovery looks like and how to start.

Jessica Miller is the Content Manager of Addiction HelpWritten by
Kent S. Hoffman, D.O. is a founder of Addiction HelpMedically reviewed by Kent S. Hoffman, D.O.
Last updated

Battling addiction & ready for help?

Find Treatment Now

What Heroin Rehab Actually Looks Like

If you are searching for heroin rehab for yourself or someone you love, you have already done the hardest part. You have named the problem. Heroin addiction is a treatable medical condition, and the treatment that works is not a locked room and gritted teeth. It is medication that switches off withdrawal and craving, paired with support that helps you rebuild a life.

The picture in your head is probably the worst version: cold sweats, sickness, white-knuckled days. That is what quitting looks like when someone tries to power through it alone, and it is not the path anyone should choose. Modern rehab is built to make withdrawal manageable and recovery durable.

People get well from this every day. The way out is gentler than you fear, and the life on the other side is better than the one you are protecting right now.

An opioid overdose can be reversed, if you act fast. Here is what to do right now.
If you or someone you love is in crisis, call or text 988 now. If breathing has slowed or stopped, call 911.

What to do:

  • Get into treatment. Methadone and buprenorphine ease withdrawal and cut the risk of overdose death, so this is the easier, safer way out. Start with supervised heroin detox and a same-visit medication start.
  • Carry naloxone (Narcan). If breathing slows or stops, give it and call 911. Relapse is a real part of this, and an opioid overdose is reversible when someone acts in time.
  • Never use alone. Tolerance falls fast after any time off, so have someone with you who can give naloxone and call for help.

Find treatment today →

AddictionHelp.com Fast Facts
  • Medication is the core of rehab, not an optional add-on — methadone and buprenorphine are the single most effective treatment there is, roughly cutting the risk of dying compared with no medication[1]
  • Care comes in levels, matched to your life — from a clinic visit and staying home up to round-the-clock residential, so rehab does not mean disappearing for months
  • Recovery is real and measurable — abstinence climbs and overdoses, ER visits, and arrests fall the longer people stay in care[2]

What Heroin Rehab Is and Where It Starts

Naming it is the hard partIf you have gotten this far, you have already done the thing most people never manage. The rest is finding the right door and walking through it.

Rehab is the stretch of structured treatment that takes over once heroin is out of your system. Detox clears the drug and gets you through withdrawal. Rehab is everything after that — the part that keeps you stable, eases cravings, and gives you something to walk toward.

If detox is the doorway, rehab is the path on the other side. The two are not the same thing, and the gap between them is dangerous. Many people finish detox and are cut loose without ongoing medication, which is exactly when relapse and overdose risk spike.

Good rehab treats heroin addiction the way medicine treats any chronic illness: a real plan, the right medication, and follow-up over time. Addiction is not a failure of character. It is a condition driven by changes in the brain’s reward and motivation circuits, the same systems that handle pleasure, learning, and stress[3].

One thing to clear up early, because it stops a lot of people from going: rehab does not mean disappearing from your life for months. For many people it means a clinic visit and staying home. The lightest level of care that keeps you safe is often the right one.

Did you know?

Most “heroin” sold in the United States today is actually illicit fentanyl or a fentanyl-adulterated product, not heroin[3]. That is why this matters for rehab: fentanyl is far more potent, harder to dose, and it lingers in body fat, which changes how detox and medication starts are handled. If you are using street “dope,” plan as if fentanyl is in it, because it almost certainly is.

Medication Is the Core of Heroin Treatment, Not an Add-On

This is the single most important thing to understand about heroin rehab, so it gets said plainly. Medication is not a crutch and not swapping one drug for another. It is the treatment, and it is what keeps people alive.

Three medications are FDA-approved for opioid addiction, together known as MAT (medication-assisted treatment) or MOUD (medications for opioid use disorder). Two of them, methadone and buprenorphine, do the heavy lifting. Both gently and steadily occupy the same brain receptors heroin hit, which switches off withdrawal and quiets craving without the high and the crash.

Medication Roughly Cuts the Risk of Dying

The evidence is not subtle:

On the medication is the recoveryMethadone and buprenorphine are not a halfway step or a substitute high. For most people they are the thing that holds recovery together.

Here is how the three medications compare in plain terms.

  • Being on methadone or buprenorphine is tied to roughly half the risk of death compared with no medication[1].
  • Opioid agonist therapy is linked to about a 50 percent drop in mortality across studies[4].
  • When researchers lined up every common approach side by side, only treatment with buprenorphine or methadone was tied to lower overdose risk. Detox-only and abstinence-only programs were not[5].

How the Three Medications Compare

Medication How it works Who it tends to fit
Methadone A long-acting full opioid agonist that fully blocks withdrawal and craving; taken daily, usually at a licensed clinic at first Severe or long-standing heroin use, high tolerance, fentanyl exposure, or people who have not held stability on buprenorphine[6]
Buprenorphine (Suboxone) A partial agonist with a built-in safety ceiling on slowed breathing; film, tablet, or monthly injection Prescribed in a regular doctor’s office or by telehealth; strong fit for milder cases, busy lives, or limited clinic access[7]
Naltrexone (Vivitrol) A monthly shot that blocks opioids entirely, with no opioid effect of its own People fully off opioids already, or leaving a controlled setting; requires a hard opioid-free gap before the first dose[8]

No single medication is best for everyone. The right one depends on how severe the addiction is, your other health, whether you can get to a clinic, and what you prefer. What is not negotiable is access to one of them.

Two reassurances are worth stating outright, because they keep people from accepting help:

  • Being on methadone or buprenorphine is not “still using.” It is the recovery, and the medical evidence is unambiguous on that point.
  • Staying on it long-term is not weakness. Every additional month of treatment independently lowers the odds of returning to use, a 25 percent drop per month on buprenorphine and 17 percent on methadone in one large study[9]. Many people stay on it for years, the way someone manages blood pressure, and that is a treatment working, not failing.

The Levels of Care, from Medical Detox to Sober Living

Level of careA clinician’s term for how much support a treatment setting provides, from a short office visit at the lighter end to living on-site with staff present at the most intensive. The aim is to find the lightest setting that still keeps you safe.

Rehab is not one-size-fits-all. Care is offered in levels, and a good program matches you to the right intensity rather than selling you the most expensive one. People often start higher and step down as they stabilize.

What Each Level of Care Looks Like

Here is what each level looks like and who it tends to fit.

Level of care What it looks like Who it fits
Medical detox A few days to a week of supervised withdrawal, with medication to ease symptoms and a same-visit start on methadone or buprenorphine Anyone coming off heroin or fentanyl; the safe entry point, not a treatment by itself
Inpatient / residential Living at a facility for weeks to a few months, with care around the clock Severe addiction, an unsafe or chaotic home, co-occurring crises, or when earlier attempts have not held
Partial hospitalization (PHP) Several hours a day, most days of the week, while you sleep at home A strong step-down from residential, or a step-up when outpatient is not enough
Intensive outpatient (IOP) A few hours a day, a few days a week, around work and family People with some stability and support who still need real structure
Standard outpatient A clinic visit and medication management, often weekly or less Milder cases, or later in recovery; many people on buprenorphine are managed entirely here[10]
Sober living A substance-free home with peers, often alongside outpatient care Anyone who needs a stable place to land while the rest of life gets rebuilt

How to Read the Levels Without the Marketing

A few rules cut through the sales pitch:

  • Detox is a doorway, not a finish line. Detox-only care is tied to relapse and poor outcomes, while continuing onto methadone or buprenorphine produces far better results[11].
  • Residential is not automatically “better.” It is the right tool for severe or unsafe situations, but plenty of people recover fully in outpatient care without ever leaving home.
  • Any program worth your time offers methadone or buprenorphine. Not all residential programs do, and the ones that do produce better outcomes. Ask before you commit.
  • The handoff is the danger point. The most dangerous moment in the whole system is leaving a program with no ongoing medication. The right program plans for what comes after from day one.
Did you know?

Skip the programs that promise to make you “sleep through” withdrawal under anesthesia. Rapid and ultra-rapid detox has been linked to deaths, shows no real edge in keeping people in recovery, and leaves the same dangerous drop in tolerance afterward[11]. The American Society of Addiction Medicine advises against it. A standard medical start is safer and works better.

Why Methadone Has the Longest Track Record for Heroin

For severe, long-standing heroin addiction, methadone has the deepest evidence base of any treatment. It has been studied for decades, and the results hold up.

The Cochrane Collaboration, the gold standard for medical evidence, found that methadone is more than three times as effective as non-medication approaches at keeping people in treatment, and it cuts heroin use by 68 percent compared with no medication[12]. A large 2023 review and meta-analysis found methadone holds a retention edge over buprenorphine, keeping more people in care at six months[13].

Two features explain why it works so well for heavy use:

  • A full opioid agonist. At the right dose it completely covers withdrawal and craving where a partial medication might fall short. In a controlled study, an adequate methadone dose produced a full blockade of heroin’s effects[14].
  • A long half-life. Steady blood levels flatten the peaks and valleys that drive the using cycle.

The trade-off is structure. Methadone for addiction is dispensed through licensed opioid treatment programs, which means daily, in-person, supervised dosing at first. For someone with severe heroin or fentanyl use, that daily structure is often exactly what holds recovery together. As stability builds, take-home doses are earned, and 2024 rules let clinics grant them sooner.

Buprenorphine and the Office-Based Path

Office-based treatmentCare you get from a regular doctor or nurse practitioner during an ordinary appointment, rather than at a dedicated addiction clinic. It folds recovery into normal healthcare, often close to home.

Buprenorphine (Suboxone) is the medication most people can start without ever setting foot in a specialty clinic. A regular doctor, a nurse practitioner, or a telehealth visit can prescribe it, and for many people it is the simplest way in.

It is a partial agonist, which gives it a built-in safety feature: a ceiling on slowed breathing, so on its own it rarely causes a fatal overdose the way full opioids can. It can be started right in an emergency department at the moment of crisis, and in a large fentanyl-era trial, serious complications during the start were rare[7].

One heroin-specific wrinkle is worth knowing. Because today’s supply is usually fentanyl, which lingers in the body, starting buprenorphine too soon can trigger a sharp withdrawal called precipitated withdrawal. Clinics handle this with careful timing or a low-dose start, and the fear of it is bigger than the reality. The takeaway is simple: this is a reason to start with a knowledgeable provider, not a reason to avoid the medication that keeps people alive.

Where Naltrexone (Vivitrol) Fits

Naltrexone (Vivitrol) is the third option, and it works differently from the other two. It contains no opioid at all. The monthly shot blocks opioid receptors, so using does not produce a high. It causes no physical dependence, and stopping it brings no withdrawal.

The catch is real and specific to heroin and fentanyl use: you have to be fully opioid-free, usually 7 to 10 days, before the first dose. Getting through that gap while actively using is genuinely hard, and many people do not make it. Across trials, fewer than 1 in 4 people injecting heroin successfully started it as outpatients, while an inpatient setting roughly doubled or tripled those odds[8].

That makes naltrexone a strong fit in specific situations rather than a first move for someone using on the street:

  • Leaving jail, prison, or residential care, where the opioid-free gap is already cleared.
  • Stabilized in detox, for people who want a non-opioid medication.
  • Once started, it reliably reduces illicit opioid use[15].

If a program offers only naltrexone and refuses to discuss methadone or buprenorphine, that is usually an administrative choice, not a medical one. You deserve the full menu.

Therapy and Support that Make Medication Work Better

Medication and therapy are partnersThink of them as two halves of one plan, not a choice between them. One steadies the body so the other can do its work on the mind and the daily life around it.

Medication does the biological work of holding withdrawal and craving down. Therapy handles everything else — the triggers, the relationships, the reasons it started, and the skills for a life that does not revolve around using. Together they do more than either alone.

Counseling Helps, but It Should Never Block the Medication

The evidence comes with one firm guardrail. Counseling improves recovery, but it should never be a precondition for getting medication. National guidelines are explicit that psychosocial treatment must not be mandatory, because forcing people to attend counseling before they can get a life-saving medication just keeps them away from it[6]. In fact, when researchers added structured therapy to buprenorphine, it produced no significant bump in staying-power on its own[16]. So the right order is: get the medication, then add the support that fits.

The approaches with the best track record include:

  • Cognitive behavioral therapy (CBT) helps you spot and change the thoughts and situations that drive use[17].
  • Mindfulness-based relapse prevention builds skills for riding out cravings and stress[17].
  • Counseling layered onto methadone modestly improves both staying in treatment and cutting drug use[18].
  • Peer support through Narcotics Anonymous, SMART Recovery, or a recovery community. Seek out groups that support medication rather than frown on it.

One more reason support matters: heroin addiction rarely travels alone. Most people with opioid addiction also struggle with another substance, with about 60 percent carrying a second substance use disorder[19]. Depression, anxiety, PTSD, and ADHD are all common alongside it, affecting roughly a third, a third, a fifth, and a fifth of people respectively[20]. A program that treats those at the same time keeps people in recovery longer.

How to Choose a Program and Pay for It

Worth asking on the call“If I finish your program, who keeps prescribing my medication, and how do you make sure I do not fall through the gap?” The answer tells you a lot.

The right program is not the one with the nicest website. It is the one that fits how severe things are, treats your whole health, and keeps supporting you after the intensive part ends.

Use these questions when you call:

  • “Do you offer methadone, buprenorphine, or naltrexone?” If the answer is no, or “we get people off all drugs,” keep looking. Medication is the core.
  • “Will you treat my depression, anxiety, or other conditions at the same time?” Integrated care keeps people in treatment longer.
  • “What happens after I finish, and who keeps prescribing my medication?” A real plan for the handoff is the difference between recovery and relapse.
  • “What level of care do I actually need?” A trustworthy program will sometimes tell you a lighter level is the right fit.

On paying for it, the landscape is more workable than people expect:

  • Insurance, including Medicaid, must cover addiction treatment as an essential health benefit under federal law, though specifics vary by plan and state.
  • Methadone clinics and federally qualified health centers often serve people on a sliding scale or at low cost, and cost-free access keeps far more people in care.
  • SAMHSA’s free helpline, 1-800-662-HELP (4357), matches you to options in your area, including low-cost and public programs.

What Recovery from Heroin Actually Looks Like

Recovery is not a single dramatic moment. It is a gradual process, and it is real and measurable. In an 18-month study of nearly 2,000 people in treatment, staying in care was tied to abstinence rising from 55 to 77 percent, with fewer overdoses, fewer emergency room visits, and fewer arrests along the way[2]. People who stuck with treatment most days needed less hospital and crisis care[21]. The pattern is consistent: the longer you stay, the better life gets.

That does not mean it is a straight line. Setbacks happen, and a return to use is a reason to adjust the plan, not a verdict on you. The truly dangerous moment is any gap in treatment, because tolerance falls fast when someone stops, so a slip after time away can be deadly in a way it would not have been before. This is exactly why staying on medication, and keeping naloxone (Narcan) within reach, matters so much. A single slip should never cost a life.

You Can Take the First Step Today

If heroin has you or someone you love in its grip, treatment works, and it is more within reach than it feels right now. The way out is not a locked room and sheer willpower. It is medical help to get through withdrawal, medication that holds craving and withdrawal down, and support that helps you rebuild, at whatever level of care fits your life.

Recovery from heroin addiction is real, and the path runs through the same door for everyone: get into care, get on medication, and stay. If you want to know what the first days feel like, the heroin withdrawal timeline takes some of the fear out of week one.

If any of this lands, the next step doesn’t have to be a big one. Our treatment centers directory can point you to the right level of care. Reaching out today is a real step forward — and one you can make right now.

Frequently asked questions

Does heroin rehab actually work?

Yes. Heroin addiction is a treatable medical condition, and the treatments that work are well understood. The most effective is medication for opioid use disorder: compared with no medication, being on methadone or buprenorphine is tied to roughly half the risk of death[1], and opioid agonist therapy is linked to about a 50 percent drop in mortality across studies[4]. In one 18-month study, staying in treatment was associated with abstinence rising from 55 to 77 percent, with fewer overdoses, ER visits, and arrests[2]. Recovery is real, and it gets more solid the longer you stay in care.

What are the levels of care in heroin rehab?

Treatment is offered at different intensities, and a good program matches you to the right one. Medical detox is the supervised entry point, a few days to a week with medication to ease withdrawal. Inpatient or residential care means living at a facility for weeks to months with round-the-clock support, best for severe addiction or an unsafe home. Partial hospitalization (PHP) and intensive outpatient (IOP) give structured hours during the day while you sleep at home. Standard outpatient is a clinic visit and medication management, often weekly, and many people on buprenorphine are managed entirely this way[10]. Sober living offers a substance-free home alongside outpatient care. People often start higher and step down as they stabilize.

Is medication-assisted treatment just trading one drug for another?

No, and this is one of the most damaging myths in recovery. Methadone and buprenorphine steadily occupy the same brain receptors heroin hit, but without the high and crash, which lets the brain stabilize and craving settle. Being on them is the recovery, not a detour from it. The evidence is unambiguous: only treatment with buprenorphine or methadone was tied to lower overdose risk when every common approach to opioid addiction was compared head to head[5]. Staying on medication is not ‘still using.’ It is the thing that keeps people alive.

Which medication is best for heroin: methadone, buprenorphine, or naltrexone?

No single medication is best for everyone. Methadone has the longest track record for heroin and the strongest hold on people with severe, long-standing use, keeping more in treatment at six months than buprenorphine[13], but it requires daily clinic visits at first. Buprenorphine (Suboxone) can be prescribed in a regular doctor’s office or by telehealth and has a built-in safety ceiling, making it a strong fit for milder cases or busy lives. Naltrexone (Vivitrol) is a non-opioid monthly shot, but you must be fully opioid-free for 7 to 10 days before the first dose, which is hard for people actively using heroin, fewer than 1 in 4 successfully start it as outpatients[8]. The right choice depends on severity, your health, clinic access, and preference.

Do I have to do counseling to get the medication?

No, and you should be cautious of any program that says you must. Counseling genuinely helps when it is paired with medication, but national guidelines are explicit that it should not be mandatory, because forcing people to attend therapy before they can get a life-saving medication just keeps them away from treatment[6]. When researchers added structured therapy to buprenorphine, it produced no significant improvement in staying in treatment on its own[16]. The right order is to get the medication first, then add the support that fits you.

Does it matter that today's heroin is cut with fentanyl?

Yes, and it makes getting into treatment more urgent, not less. Most ‘heroin’ sold in the United States today is actually illicit fentanyl or a fentanyl-adulterated product[3]. Fentanyl is far more potent, harder to dose, and lingers in body fat, which changes how detox and medication starts are handled, and it makes overdose more likely on every use. Practically, that means keeping naloxone (Narcan) within reach, never using alone, and starting medication with a knowledgeable provider. Because fentanyl binds hard, one dose of naloxone is often not enough; multiple doses are now the rule in a fentanyl-involved overdose[22].

Get Treatment Help

If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.

Exclusive offer: 20% Off BetterHelp*

Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.

22 Sources
  1. Harris, Miriam T H, Weinstein, Zoe M, Walley, Alexander Y (2026). Medications for Opioid Use Disorder, Opioid Withdrawal, and Opioid Overdose: A Review. JAMA. https://doi.org/10.1001/jama.2025.26348
  2. Dever, Jill A, Hertz, Marci F, Dunlap, Laura J, Richardson, John S, Wolicki, Sara Beth, Biggers, Bradley B, Edlund, Mark J, Bohm, Michele K, Turcios, Didier, Jiang, Xinyi, Zhou, Hong, Evans, Mary E, Guy, Gery P (2024). The Medications for Opioid Use Disorder Study: Methods and Initial Outcomes From an 18-Month Study of Patients in Treatment for Opioid Use Disorder. Public health reports (Washington, D.C. : 1974). https://doi.org/10.1177/00333549231222479
  3. Carroll Turpin, Michelle A, Starks, Steven M, Grissom, Maureen O, Reed, Brian C (2024). Addiction Medicine: Opioid Use Disorder. FP essentials.
  4. Perry, Danielle, Kirkwood, Jessica Em, Doroshuk, Marissa L, Kelmer, Michael, Korownyk, Christina S, Ton, Joey, Garrison, Scott R (2025). Opioid agonist therapy for opioid use disorder in primary versus specialty care. The Cochrane database of systematic reviews. https://doi.org/10.1002/14651858.cd013672.pub2
  5. Wakeman, Sarah E, Larochelle, Marc R, Ameli, Omid, Chaisson, Christine E, McPheeters, Jeffrey Thomas, Crown, William H, Azocar, Francisca, Sanghavi, Darshak M (2020). Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder. JAMA network open. https://doi.org/10.1001/jamanetworkopen.2019.20622
  6. Yakovenko, Igor, Mukaneza, Yvette, Germé, Katuschia, Belliveau, Jacob, Fraleigh, Ross, Bach, Paxton, Poulin, Ginette, Selby, Peter, Goyer, Marie-Ève, Brothers, Thomas D, Rehm, Jürgen, Hodgins, David C, Stewart, Sherry H, Wood, Evan, Bruneau, Julie, Canadian Research Initiative in Substance Matters guideline development team (2024). Management of opioid use disorder: 2024 update to the national clinical practice guideline. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. https://doi.org/10.1503/cmaj.241173
  7. D'Onofrio, Gail, Herring, Andrew A, Hawk, Kathryn F, Perrone, Jeanmarie, Cowan, Ethan, McCormack, Ryan P, Dziura, James, Matthews, Abigail G, Pantalon, Michael V, Owens, Patricia, Martel, Shara, Coupet, Edouard, Lofwall, Michele R, Walsh, Sharon L, Edelman, E Jennifer, Carpenter, Joseph E, Strout, Tania D, Baumann, Michael R, Anderson, Erik, Barrett, Tyler W, Dorey, Alyrene, Taillac, Peter, Cochran, Gerald, Crandall, Cameron S, Wilson, Jason, Manteuffel, Jacob, Cole, Jon B, Whiteside, Lauren K, Jones, Christopher, Samuels, Elizabeth, Huntley, Kristen, Fiellin, David A, ED INNOVATION Investigators (2026). Emergency Department-Initiated Buprenorphine for Opioid Use Disorder: A Randomized Clinical Trial. JAMA. https://doi.org/10.1001/jama.2025.27019
  8. Shulman, Matisyahu, Hu, Mei-Chen, Sullivan, Maria A, Akerman, Sarah C, Fratantonio, James, Barbieri, Vincent, Nunes, Edward V, Bisaga, Adam (2022). Patient characteristics associated with initiation of XR-naltrexone for opioid use disorder in clinical trials. Drug Alcohol Depend. https://doi.org/10.1016/j.drugalcdep.2022.109343
  9. Jiang, Xinyi, Guy, Gery P, Dever, Jill A, Richardson, John S, Dunlap, Laura J, Turcios, Didier, Wolicki, Sara Beth, Edlund, Mark J, Losby, Jan L (2025). Association Between Length of Buprenorphine or Methadone Use and Nonprescribed Opioid Use Among Individuals with Opioid Use Disorder: A Cohort Study. Substance use & addiction journal. https://doi.org/10.1177/29767342241266038
  10. Cope, Kevin, DeMicco, James, Salib, Justina, Michael, Mina, Yakoub, Peter, Daoud, Kirollos, Cope, Rebecca (2022). Three-year Retention Rates With Office-based Treatment of Buprenorphine for Opioid Use Disorder in a Private Family Medicine Practice. Journal of addiction medicine. https://doi.org/10.1097/adm.0000000000001009
  11. Carswell, Nico, Angermaier, Giselle, Castaneda, Christopher, Delgado, Fabrizzio (2022). Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting. Hospital practice (1995). https://doi.org/10.1080/21548331.2022.2102776
  12. Mattick, R P, Breen, C, Kimber, J, Davoli, M (2003). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. The Cochrane database of systematic reviews. https://doi.org/10.1002/14651858.cd002209
  13. Degenhardt, Louisa, Clark, Brodie, Macpherson, Georgina, Leppan, Oscar, Nielsen, Suzanne, Zahra, Emma, Larance, Briony, Kimber, Jo, Martino-Burke, Daniel, Hickman, Matthew, Farrell, Michael (2023). Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies. The lancet. Psychiatry. https://doi.org/10.1016/s2215-0366(23)00095-0
  14. Donny, Eric C, Walsh, Sharon L, Bigelow, George E, Eissenberg, Thomas, Stitzer, Maxine L (2002). High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans. Psychopharmacology. https://doi.org/10.1007/s00213-002-1027-0
  15. Kornør, Hege, Lobmaier, Philipp Paul K, Kunøe, Nikolaj (2025). Sustained-release naltrexone for opioid dependence. The Cochrane database of systematic reviews. https://doi.org/10.1002/14651858.cd006140.pub3
  16. McHugh, R Kathryn, Bailey, Allen J, McConaghy, Brooke A, Weiss, Roger D, Fiellin, David A, Hillhouse, Maureen, Moore, Brent A, Fitzmaurice, Garrett M (2025). Behavioral Therapy as an Adjunct to Buprenorphine Treatment for Opioid Use Disorder: A Secondary Analysis of 4 Randomized Clinical Trials. JAMA Netw Open. https://doi.org/10.1001/jamanetworkopen.2025.28529
  17. Jiménez-Fernández, Beltrán, Calomarde-Gómez, Cristina, López-Lazcano, Ana, Lligoña, Anna, Gual, Antoni, López-Pelayo, Hugo (2023). Systematic review on the clinical management of chronic pain and comorbid opioid use disorder. Adicciones. https://doi.org/10.20882/adicciones.1680
  18. Liu, Chengbin, Li, Yangyang (2024). Psychosocial combined with methadone maintenance treatments versus methadone maintenance treatments alone for treatment of opioid use disorder: A meta-analysis. Journal of addictive diseases. https://doi.org/10.1080/10550887.2022.2158664
  19. Santo, Thomas, Gisev, Natasa, Campbell, Gabrielle, Colledge-Frisby, Samantha, Wilson, Jack, Tran, Lucy Thi, Lynch, Michelle, Martino-Burke, Daniel, Taylor, Sophia, Degenhardt, Louisa (2024). Prevalence of comorbid substance use disorders among people with opioid use disorder: A systematic review & meta-analysis. The International journal on drug policy. https://doi.org/10.1016/j.drugpo.2024.104434
  20. Santo, Thomas, Campbell, Gabrielle, Gisev, Natasa, Martino-Burke, Daniel, Wilson, Jack, Colledge-Frisby, Samantha, Clark, Brodie, Tran, Lucy Thi, Degenhardt, Louisa (2022). Prevalence of mental disorders among people with opioid use disorder: A systematic review and meta-analysis. Drug and alcohol dependence. https://doi.org/10.1016/j.drugalcdep.2022.109551
  21. Gopaldas, Manesh, Wenzel, Kevin, Campbell, Aimee N C, Jalali, Ali, Fishman, Marc, Rotrosen, John, Nunes, Edward V, Murphy, Sean M (2023). Impact of Medication-Based Treatment on Health Care Utilization Among Individuals With Opioid Use Disorder. Psychiatric services (Washington, D.C.). https://doi.org/10.1176/appi.ps.20220549
  22. Abdelal, Randa, Banerjee, A Raja, Carlberg-Racich, Suzanne, Darwaza, Neyla, Ito, Diane, Epstein, Josh (2022). The need for multiple naloxone administrations for opioid overdose reversals: A review of the literature. Substance abuse. https://doi.org/10.1080/08897077.2021.2010252
Written by
Jessica Miller is the Content Manager of Addiction Help

Editorial Director

Jessica Miller is the Editorial Director of Addiction Help. Jessica graduated from the University of South Florida (USF) with an English degree and combines her writing expertise and passion for helping others to deliver reliable information to those impacted by addiction. Informed by her personal journey to recovery and support of loved ones in sobriety, Jessica's empathetic and authentic approach resonates deeply with the Addiction Help community.

Reviewed by
  • Fact-Checked
  • Editor
Kent S. Hoffman, D.O. is a founder of Addiction Help

Co-Founder & Chief Medical Officer

Kent S. Hoffman, D.O. has been an expert in addiction medicine for more than 15 years. In addition to managing a successful family medical practice, Dr. Hoffman is board certified in addiction medicine by the American Osteopathic Academy of Addiction Medicine (AOAAM). Dr. Hoffman has successfully treated hundreds of patients battling addiction. Dr. Hoffman is the Co-Founder and Chief Medical Officer of AddictionHelp.com and ensures the website’s medical content and messaging quality.

Real Help. Real Recovery.

Compare centers, explore options and start your path to recovery today.

Find Treatment Now

"AddictionHelp.com is helping to make recovery available to EVERYONE!"

- Angela N.